These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7655459)

  • 1. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice.
    Sunada Y; Bernier SM; Utani A; Yamada Y; Campbell KP
    Hum Mol Genet; 1995 Jun; 4(6):1055-61. PubMed ID: 7655459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.
    Xu H; Wu XR; Wewer UM; Engvall E
    Nat Genet; 1994 Nov; 8(3):297-302. PubMed ID: 7874173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of homozygous and heterozygous dy2J mice by PCR.
    Vilquin JT; Vignier N; Tremblay JP; Engvall E; Schwartz K; Fiszman M
    Neuromuscul Disord; 2000 Jan; 10(1):59-62. PubMed ID: 10677866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
    Pasteuning-Vuhman S; Putker K; Tanganyika-de Winter CL; Boertje-van der Meulen JW; van Vliet L; Overzier M; Plomp JJ; Aartsma-Rus A; van Putten M
    PLoS One; 2018; 13(5):e0197388. PubMed ID: 29763467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
    Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
    J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
    Körner Z; Durbeej M
    PLoS One; 2016; 11(1):e0146471. PubMed ID: 26731667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
    Moreira Soares Oliveira B; Durbeej M; Holmberg J
    PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin alpha2 chain gene.
    Besse S; Allamand V; Vilquin JT; Li Z; Poirier C; Vignier N; Hori H; Guénet JL; Guicheney P
    Neuromuscul Disord; 2003 Mar; 13(3):216-22. PubMed ID: 12609503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.
    Guo LT; Zhang XU; Kuang W; Xu H; Liu LA; Vilquin JT; Miyagoe-Suzuki Y; Takeda S; Ruegg MA; Wewer UM; Engvall E
    Neuromuscul Disord; 2003 Mar; 13(3):207-15. PubMed ID: 12609502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats.
    O'Brien DP; Johnson GC; Liu LA; Guo LT; Engvall E; Powell HC; Shelton GD
    J Neurol Sci; 2001 Aug; 189(1-2):37-43. PubMed ID: 11535231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic plasticity in the dy2J mouse model of laminin alpha2-deficient congenital muscular dystrophy.
    Anderson JL; Head SI; Morley JW
    Brain Res; 2005 Apr; 1042(1):23-8. PubMed ID: 15823249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy2J/dy2J dystrophic mouse.
    Edwards JP; Hatton PA; Wareham AC
    Brain Res; 1998 Mar; 788(1-2):262-8. PubMed ID: 9555049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.
    Xu H; Christmas P; Wu XR; Wewer UM; Engvall E
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5572-6. PubMed ID: 8202529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
    Straub V; Rafael JA; Chamberlain JS; Campbell KP
    J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
    Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
    Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.
    Sunada Y; Bernier SM; Kozak CA; Yamada Y; Campbell KP
    J Biol Chem; 1994 May; 269(19):13729-32. PubMed ID: 8188645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype.
    McKee KK; Crosson SC; Meinen S; Reinhard JR; Rüegg MA; Yurchenco PD
    J Clin Invest; 2017 Mar; 127(3):1075-1089. PubMed ID: 28218617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy.
    Gawlik KI; Li JY; Petersén A; Durbeej M
    Hum Mol Genet; 2006 Sep; 15(18):2690-700. PubMed ID: 16893907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers.
    Colognato H; Yurchenco PD
    Curr Biol; 1999 Nov; 9(22):1327-30. PubMed ID: 10574769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain.
    Allamand V; Sunada Y; Salih MA; Straub V; Ozo CO; Al-Turaiki MH; Akbar M; Kolo T; Colognato H; Zhang X; Sorokin LM; Yurchenco PD; Tryggvason K; Campbell KP
    Hum Mol Genet; 1997 May; 6(5):747-52. PubMed ID: 9158149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.